All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

STAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals

By

Ed Silverman

2d ago

Source

STATSTAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitalsstatnews.com
Snippet from the RSS feed
Lawmakers step into a dispute between Eli Lilly and hospitals about the 340b drug discount program.

You might also wanna read

Indiana Enacts Hospital Price Caps to Curb Employer Healthcare Costs

Indiana, a Republican-controlled state, has enacted a law capping prices that five of its largest nonprofit hospital systems can charge for

cobbcountycourier.com·11d ago

Starmer's US pharma deal criticized as costly threat to NHS funding and public health

Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law enabling a US pharma deal that will harm the NHS by costi

theguardian.com·2d ago

Senators Investigate Pharmaceutical Companies' Direct-to-Consumer Telehealth Platforms for Steering Patients to High-Cost Drugs

U.S. senators are investigating direct-to-consumer (DTC) telehealth platforms operated by pharmaceutical companies like Eli Lilly and Pfizer

arstechnica.com·5mo ago

How the 340B Drug Pricing Program Shifts Tax Burden to Local Communities Through Hospital Expansion

The article examines how the 340B Drug Pricing Program, originally designed to subsidize safety-net healthcare for low-income patients, has

pricepoints.health·4mo ago

Starmer's US pharma deal criticized as costly threat to NHS and public health

Guardian columnist Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law facilitating a US medicine import deal

theguardian.com·3d ago

Starmer's US pharma deal criticized as costly, harmful to NHS, and a democratic failure

Guardian columnist Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law enabling a US pharma deal that will ha

theguardian.com·3d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.